Osteopontin overexpression predicts poor prognosis of upper urinary tract urothelial carcinoma. (Q53303542)

13 May 2018

title

Osteopontin overexpression predicts poor prognosis of upper urinary tract urothelial carcinoma. (English)

1 reference

13 May 2018

1 reference

Hung-Lung Ke

1 reference

13 May 2018

Lin-Li Chang

1 reference

13 May 2018

Sheau-Fang Yang

1 reference

13 May 2018

Hui-Hui Lin

1 reference

13 May 2018

Ching-Chia Li

1 reference

13 May 2018

Deng-Chyang Wu

1 reference

13 May 2018

Wen-Jeng Wu

1 reference

13 May 2018

publication date

21 December 2009

1 reference

13 May 2018

published in

Urologic Oncology

1 reference

13 May 2018

volume

1 reference

13 May 2018

issue

1 reference

13 May 2018

page(s)

703-709

1 reference

13 May 2018

Unusual clinical presentation of upper urothelial carcinoma in Taiwan

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

Tumor grade and stage as prognostic variables in upper tract urothelial tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

Prognostic variables in patients with transitional cell carcinoma of the renal pelvis and proximal ureter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

Osteopontin: role in cell signaling and cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

The role of Osteopontin in tumor metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

Role of osteopontin in tumour progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

Plasma osteopontin levels are predictive of disease stage in patients with transitional cell carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

Tubular osteopontin expression in human glomerulonephritis and renal vasculitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

Upregulation of osteopontin gene expression in diabetic rat proximal tubular cells revealed by microarray profiling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

Osteopontin and mucosal protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

Clinical significance of osteopontin expression in cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

Serum levels of osteopontin are increased in SIRS and sepsis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.10.009

10.1016/J.UROLONC.2009.10.009

7 January 2021

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018